Senores Pharmaceuticals
Listed
Listed
IPO Timeline
Issue open date
20 Dec 2024Issue close date
24 Dec 2024UPI mandate deadline
24 Dec 2024Allotment finalization
26 Dec 2024Refund initiation
27 Dec 2024Share credit
27 Dec 2024Listing date
30 Dec 2024Mandate end date
8 Jan 2025Lock-in end date for anchor investors (50%)
25 Jan 2025Lock-in end date for anchor investors (remaining)
26 Mar 2025Key Dates
Open
20 Dec 2024Close
24 Dec 2024Listing
30 Dec 2024Quick Stats
Issue Size:582cr
Lot Size:38 shares
About the Company
Senores Pharmaceuticals Limited is a global, research-driven pharmaceutical company specializing in developing and manufacturing complex and specialty products for regulated markets like the US, Canada, and the UK, with a presence in 43 emerging markets. The company focuses on underpenetrated and high-demand molecules, leveraging strong R&D capabilities to deliver critical care injectables, APIs, and diverse dosage forms. Trusted by partners like Prasco LLC, Sun Pharma, and Cipla USA, Senores stands out for quality, innovation, and a robust pipeline of complex pharmaceutical products.
Strengths
No strengths provided as of now. Please check back later.
Risks
- High dependence on borrowed funds.
- Regulatory hurdles in manufacturing.
- Market volatility impacts growth plans.
- Challenges in fund utilization across subsidiaries.
Senores Pharmaceuticals IPO – Frequently Asked Questions
- The price band for the Senores Pharmaceuticals IPO is set at ₹372 to ₹391 per share.
- The Senores Pharmaceuticals IPO opens on December 20, 2024 and closes on December 24, 2024.
- The tentative listing date for the Senores Pharmaceuticals IPO is December 30, 2024.
- You can apply for the Senores Pharmaceuticals IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Senores Pharmaceuticals, enter lot quantity and UPI ID, then approve the mandate.
- The lot size for the Senores Pharmaceuticals IPO is 38 shares. Investors must apply for at least one lot (i.e., 38 shares).